BioNTech (BNTX) Stock Chart & Stock Price History $111.66 +0.31 (+0.28%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$111.44 -0.22 (-0.20%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioNTech Stock Price Performance The BioNTech (BNTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.19%, with a year-to-date return of -2.01%. In the past month, the stock has decreased 1.98%, reflecting recent market activity. As of the latest close, BioNTech traded at $111.66 with a market cap of $26.84 billion and volume of 530,256 shares. Five years ago, the stock traded at $73.95, representing a 50.99% increase over that period. At the time, it had a market cap of $16.73 billion and a volume of 2.82 million shares. Receive BNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.53%1 Month Performance-1.98%3 Month Performance+20.36%Year-To-Date Performance-2.01%1 Year Performance+38.19%5 Year Performance+50.99% BNTX Stock Chart for Sunday, August, 10, 2025 BNTX Chart by TradingView BioNTech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$111.35$111.66+0.28%$112.80$111.06530,256 shs$26.84 billion08/07/2025$111.30$111.35+0.04%$114.01$111.12891,767 shs$26.77 billion08/06/2025$111.07$111.30+0.21%$111.43$108.901.18 million shs$26.76 billion08/05/2025$110.03$111.07+0.95%$111.81$108.76905,596 shs$26.70 billion08/04/2025$107.34$110.03+2.51%$115.51$109.53905,998 shs$26.45 billion08/01/2025$107.50$107.34-0.15%$107.48$104.64840,683 shs$25.80 billion07/31/2025$110.05$107.50-2.32%$110.01$106.50859,127 shs$25.84 billion07/30/2025$111.48$110.05-1.28%$113.30$109.48657,937 shs$26.45 billion07/29/2025$112.79$111.48-1.16%$112.66$109.52805,945 shs$26.80 billion07/28/2025$115.31$112.79-2.19%$114.91$112.00801,836 shs$27.11 billion Get the Latest News and Ratings for BNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$114.57$115.31+0.65%$115.54$113.54392,122 shs$27.72 billion07/24/2025$114.60$114.57-0.03%$115.09$112.65511,064 shs$27.54 billion07/23/2025$111.44$114.60+2.84%$114.89$111.32593,746 shs$27.55 billion07/22/2025$108.91$111.44+2.32%$111.56$108.55427,398 shs$26.79 billion07/21/2025$110.02$108.91-1.01%$110.93$108.63867,910 shs$26.18 billion07/18/2025$111.04$110.02-0.92%$111.78$109.48616,421 shs$26.45 billion07/17/2025$112.49$111.04-1.29%$112.58$110.82628,441 shs$26.69 billion07/16/2025$110.65$112.49+1.66%$112.55$109.07786,508 shs$26.60 billion07/15/2025$111.00$110.65-0.32%$111.81$108.72547,963 shs$26.60 billion07/14/2025$112.89$111.00-1.67%$111.85$109.85441,499 shs$26.68 billion07/11/2025$113.92$112.89-0.90%$113.72$112.06521,908 shs$27.14 billion07/10/2025$111.78$113.92+1.91%$114.00$111.76667,934 shs$27.39 billion07/09/2025$111.66$111.78+0.11%$113.29$110.58436,577 shs$26.87 billion Related Companies GSK Stock Chart Takeda Pharmaceutical Stock Chart argenex Stock Chart BeOne Medicines Stock Chart Summit Therapeutics Stock Chart Insmed Stock Chart Teva Pharmaceutical Industries Stock Chart Genmab A/S Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Receive BNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BNTX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
